[Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
D000328:Adult; D000368:Aged; D000618:Aminohippuric Acids / Q000378:metabolism; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001795:Blood Pressure Determination; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000628:therapy; D007677:Kidney Function Tests; D008875:Middle Aged; D006435:Renal Dialysis; D014882:Water-Electrolyte Balance
D000618:Aminohippuric Acids; D000959:Antihypertensive Agents; D007093:Imidazoles
Klinische Erfahrungen mit 2-(2,6-Dichlorphenylamino)-2-imidazolinhydrochlorid bei der Behandlung der renalen Hypertension.